Pictor

Pictor Limited specializes in multiplexed immunodiagnostic technology, focusing on high throughput antibody testing systems. The company operates in the healthcare diagnostics market, serving medical laboratories and healthcare providers. Pictor's core product is the PictArray™ SARS CoV 2 ELISA Kit, which, in collaboration with SCIENION, is used for international commercialization. This kit allows for the detection of multiple analytes in a single test, specifically IgG antibodies to both the Spike Protein and Nucleocapsid Protein of SARS CoV 2. This capability leads to better health outcomes through earlier diagnosis, prevention, and treatment of COVID-19. Pictor's business model revolves around selling these diagnostic kits and related imaging systems, generating revenue through product sales and strategic partnerships. The company aims to enhance cost-effective and efficient operations in the diagnostics field.

Keywords: multiplexed immunodiagnostics, SARS CoV 2, antibody testing, PictArray, ELISA Kit, SCIENION, healthcare diagnostics, early diagnosis, COVID-19, medical laboratories.